Last Updated:
Name Designation Appointment Date Status
Naveen Kumar Venkatesan

Appointed as Director since March 2018

Director 22-Mar-2018 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Mottaireddy Venkatesan

Appointed as Director since March 2018

Director 22-Mar-2018 Current
Vinayagam Samyuktha

Appointed as Director since August 2024

Director 16-Aug-2024 Current

People Timeline

Explore the timeline of key personnel in Immugenix Biosciences Private Limited's leadership journey.

Loading...
Contact Details
  • Address No. 81/53, Nattal Garden 2Nd Street, Perambur, Chennai Tamil Nadu, 600011, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Immugenix Biosciences Private Limited?
You can contact Immugenix Biosciences Private Limited through their registered address at No. 81/53, Nattal Garden 2Nd Street, Perambur, Chennai Tamil Nadu, 600011, India, or via their website at immugenixbio.com. Social media links are also provided where applicable.
Who are the current directors of Immugenix Biosciences Private Limited?
The current directors of Immugenix Biosciences Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MOTTAIREDDY VENKATESAN
  • NAVEEN KUMAR VENKATESAN
  • Vinayagam Samyuktha
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available